Severe acute respiratory syndrome coronavirus 2 human challenge trials: Too risky, too soon

Liza Dawson; Jake Earl; Jeffrey Livezey

doi:10.1093/infdis/jiaa314

Severe acute respiratory syndrome coronavirus 2 human challenge trials: Too risky, too soon

Liza Dawson^*
, Jake Earl
, Jeffrey Livezey

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Letter › peer-review

27 Scopus citations

Original language	English
Pages (from-to)	514-516
Number of pages	3
Journal	Journal of Infectious Diseases
Volume	222
Issue number	3
DOIs	https://doi.org/10.1093/infdis/jiaa314
State	Published - 1 Aug 2020

Access to Document

10.1093/infdis/jiaa314

Cite this

@article{3634fd4379044d2883066aa16f83619b,

title = "Severe acute respiratory syndrome coronavirus 2 human challenge trials: Too risky, too soon",

author = "Liza Dawson and Jake Earl and Jeffrey Livezey",

year = "2020",

month = aug,

day = "1",

doi = "10.1093/infdis/jiaa314",

language = "English",

volume = "222",

pages = "514--516",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Severe acute respiratory syndrome coronavirus 2 human challenge trials

T2 - Too risky, too soon

AU - Dawson, Liza

AU - Earl, Jake

AU - Livezey, Jeffrey

PY - 2020/8/1

Y1 - 2020/8/1

UR - https://www.scopus.com/pages/publications/85087532986

U2 - 10.1093/infdis/jiaa314

DO - 10.1093/infdis/jiaa314

M3 - Letter

C2 - 32496536

AN - SCOPUS:85087532986

SN - 0022-1899

VL - 222

SP - 514

EP - 516

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 3

ER -

Severe acute respiratory syndrome coronavirus 2 human challenge trials: Too risky, too soon

Access to Document

Fingerprint

Cite this